• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利什曼病中的趋化因子特征与T细胞动态:分子洞察与治疗应用

Chemokines Signature and T Cell Dynamics in Leishmaniasis: Molecular insight and therapeutic application.

作者信息

Upadhyay Shreya, Kumar Shashi, Singh Vishal Kumar, Tiwari Rahul, Kumar Awnish, Sundar Shyam, Kumar Rajiv

出版信息

Expert Rev Mol Med. 2024 Nov 26;27:1-55. doi: 10.1017/erm.2024.36.

DOI:10.1017/erm.2024.36
PMID:39587036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11707835/
Abstract

Leishmaniasis, caused by obligate intracellular parasites, poses a significant global health burden. The control of infection relies on an effective T cell-dependent immune response; however, various factors impede the host’s ability to mount a successful defence. Alterations in the chemokine profile, responsible for cell trafficking to the infection site, can disrupt optimal immune responses and influence the outcome of pathogenesis by facilitating parasite persistence. This review aims to emphasize the significance of the chemokine system in T cell responses and to summarize the current knowledge on the dysregulation of chemokines and their receptors associated with different subsets of T lymphocytes during Leishmaniasis. A comprehensive understanding of the dynamic nature of the chemokine system during Leishmaniasis is crucial for the development of successful immunotherapeutic approaches.

摘要

利什曼病由专性细胞内寄生虫引起,给全球健康带来重大负担。感染的控制依赖于有效的T细胞依赖性免疫反应;然而,多种因素阻碍宿主成功进行防御的能力。负责细胞向感染部位迁移的趋化因子谱的改变,会破坏最佳免疫反应,并通过促进寄生虫持续存在来影响发病机制的结果。本综述旨在强调趋化因子系统在T细胞反应中的重要性,并总结目前关于利什曼病期间与不同T淋巴细胞亚群相关的趋化因子及其受体失调的知识。全面了解利什曼病期间趋化因子系统的动态性质对于开发成功的免疫治疗方法至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e4/11707835/41ae4922c62e/S146239942400036X_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e4/11707835/14b0cf4f4ed8/S146239942400036X_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e4/11707835/4f752a1ad3f2/S146239942400036X_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e4/11707835/41ae4922c62e/S146239942400036X_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e4/11707835/14b0cf4f4ed8/S146239942400036X_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e4/11707835/4f752a1ad3f2/S146239942400036X_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00e4/11707835/41ae4922c62e/S146239942400036X_fig3.jpg

相似文献

1
Chemokines Signature and T Cell Dynamics in Leishmaniasis: Molecular insight and therapeutic application.利什曼病中的趋化因子特征与T细胞动态:分子洞察与治疗应用
Expert Rev Mol Med. 2024 Nov 26;27:1-55. doi: 10.1017/erm.2024.36.
2
Chemokines in Leishmaniasis: Map of cell movements highlights the landscape of infection and pathogenesis.利什曼病中的趋化因子:细胞运动图谱突出了感染和发病机制的景观。
Cytokine. 2021 Nov;147:155339. doi: 10.1016/j.cyto.2020.155339. Epub 2020 Dec 7.
3
Leishmaniasis and IFN-γ dependent chemokines.利什曼病与干扰素-γ依赖性趋化因子
Clin Ter. 2016 Sep-Oct;167(5):e117-e122. doi: 10.7417/CT.2016.1954.
4
Differential expression of chemokines in patients with localized and diffuse cutaneous American leishmaniasis.趋化因子在局限性和播散性皮肤美洲利什曼病患者中的差异表达
J Infect Dis. 1996 Mar;173(3):699-709. doi: 10.1093/infdis/173.3.699.
5
Senescence-related genes are associated with the immunopathology signature of American tegumentary leishmaniasis lesions and may predict progression to mucosal leishmaniasis.衰老相关基因与美洲皮肤利什曼病病变的免疫病理学特征相关,并且可能预测向黏膜利什曼病的进展。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae088.
6
Chemokines in host-parasite interactions in leishmaniasis.利什曼病宿主-寄生虫相互作用中的趋化因子
Trends Parasitol. 2006 Jan;22(1):32-40. doi: 10.1016/j.pt.2005.11.010. Epub 2005 Nov 23.
7
Chemokines and chemokine receptors expression in the lesions of patients with American cutaneous leishmaniasis.趋化因子及其受体在美洲皮肤利什曼病患者皮损中的表达。
Mem Inst Oswaldo Cruz. 2013 Jun;108(4):446-52. doi: 10.1590/S0074-0276108042013008.
8
Transcriptomic landscape of skin lesions in cutaneous leishmaniasis reveals a strong CD8 T cell immunosenescence signature linked to immunopathology.皮肤利什曼病皮损的转录组图谱揭示了与免疫病理学相关的强烈的CD8 T细胞免疫衰老特征。
Immunology. 2021 Dec;164(4):754-765. doi: 10.1111/imm.13410. Epub 2021 Sep 1.
9
Role of chemokines in regulation of immunity against leishmaniasis.趋化因子在调节抗利什曼病免疫中的作用。
Exp Parasitol. 2010 Nov;126(3):389-96. doi: 10.1016/j.exppara.2010.02.010. Epub 2010 Mar 3.
10
Chemokines and chemokine receptors coordinate the inflammatory immune response in human cutaneous leishmaniasis.趋化因子及其受体协调人类皮肤利什曼病中的炎症免疫反应。
Hum Immunol. 2010 Dec;71(12):1220-7. doi: 10.1016/j.humimm.2010.09.002. Epub 2010 Sep 18.

本文引用的文献

1
CCR5 promotes the migration of pathological CD8+ T cells to the leishmanial lesions.CCR5 促进病理 CD8+T 细胞向利什曼病病变部位的迁移。
PLoS Pathog. 2024 May 6;20(5):e1012211. doi: 10.1371/journal.ppat.1012211. eCollection 2024 May.
2
Ectopic CXCR2 expression cells improve the anti-tumor efficiency of CAR-T cells and remodel the immune microenvironment of pancreatic ductal adenocarcinoma.异位 CXCR2 表达细胞可提高 CAR-T 细胞的抗肿瘤效率并重塑胰腺导管腺癌的免疫微环境。
Cancer Immunol Immunother. 2024 Mar 2;73(4):61. doi: 10.1007/s00262-024-03648-y.
3
Altered IL-7 signaling in CD4+ T cells from patients with visceral leishmaniasis.
内脏利什曼病患者 CD4+T 细胞中白细胞介素-7 信号的改变。
PLoS Negl Trop Dis. 2024 Feb 26;18(2):e0011960. doi: 10.1371/journal.pntd.0011960. eCollection 2024 Feb.
4
The chemokine receptor CXCR3 promotes CD8 T cell-dependent lung pathology during influenza pathogenesis.趋化因子受体 CXCR3 在流感发病期间促进 CD8 T 细胞依赖性肺部病理。
Sci Adv. 2024 Jan 5;10(1):eadj1120. doi: 10.1126/sciadv.adj1120. Epub 2024 Jan 3.
5
Immune mechanisms of granuloma formation in sarcoidosis and tuberculosis.结节病和结核病肉芽肿形成的免疫机制。
J Clin Invest. 2024 Jan 2;134(1):e175264. doi: 10.1172/JCI175264.
6
The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML).CXCR1、CXCR2、CXCR3、CXCR5和CXCR6配体在急性髓系白血病(AML)分子癌症进程及临床方面的作用
Cancers (Basel). 2023 Sep 14;15(18):4555. doi: 10.3390/cancers15184555.
7
CXCR6 orchestrates brain CD8 T cell residency and limits mouse Alzheimer's disease pathology.CXCR6 调控大脑 CD8 T 细胞的定居,并限制小鼠阿尔茨海默病的病理。
Nat Immunol. 2023 Oct;24(10):1735-1747. doi: 10.1038/s41590-023-01604-z. Epub 2023 Sep 7.
8
CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8 T cell antitumor immunity.CXCR3 在调节性 T 细胞中的表达驱动其与肿瘤中 I 型树突状细胞的相互作用,从而限制 CD8 T 细胞的抗肿瘤免疫。
Immunity. 2023 Jul 11;56(7):1613-1630.e5. doi: 10.1016/j.immuni.2023.06.003. Epub 2023 Jun 30.
9
T cells in health and disease.健康与疾病中的 T 细胞。
Signal Transduct Target Ther. 2023 Jun 19;8(1):235. doi: 10.1038/s41392-023-01471-y.
10
CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases.CCR6作为治疗炎症性疾病的治疗性抗体的潜在靶点。
Antibodies (Basel). 2023 Apr 20;12(2):30. doi: 10.3390/antib12020030.